Understanding T cell responses to COVID-19 is essential for informing public health strategies. Review uri icon

Overview

abstract

  • Durable T cell responses to SARS-CoV-2 antigens after infection or vaccination improve immune-mediated viral clearance. To date, population-based surveys of COVID-19 adaptive immunity have focused on testing for IgG antibodies that bind spike protein and/or neutralize the virus. Deployment of existing methods for measuring T cell immunity could provide a more complete profile of immune status, informing public health policies and interventions.

publication date

  • May 20, 2022

Research

keywords

  • COVID-19

Identity

PubMed Central ID

  • PMC10344642

Scopus Document Identifier

  • 85129347803

Digital Object Identifier (DOI)

  • 10.1126/sciimmunol.abo1303

PubMed ID

  • 35324269

Additional Document Info

volume

  • 7

issue

  • 71